Pharma & Healthcare
Global Sevoflurane Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Apr 07, 25
- ID: 178007
- Pages: 78
- Figures: 76
- Views: 7
The global Sevoflurane market size was US$ 1195 million in 2024 and is forecast to a readjusted size of US$ 1527 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.
The key driver for the Sevoflurane market is the increasing number of surgeries worldwide, driven by the aging population and the rising prevalence of chronic conditions requiring surgical intervention. Sevoflurane is highly preferred due to its rapid onset and recovery, making it ideal for both pediatric and adult patients, particularly in outpatient surgeries. Technological advancements in anesthesia delivery systems and the growing demand for minimally invasive procedures have also contributed to the rising adoption of Sevoflurane in clinical settings. Furthermore, the safety and effectiveness of Sevoflurane in maintaining stable cardiovascular function during anesthesia have enhanced its demand.
One of the main challenges in the Sevoflurane market is its high cost compared to other anesthetic agents, which can limit its accessibility in low- and middle-income regions. Additionally, environmental concerns regarding the use of volatile anesthetics like Sevoflurane, which contribute to greenhouse gas emissions, have led to increased scrutiny and calls for more sustainable alternatives. Regulatory restrictions and the availability of generic alternatives may further impact the market growth, as healthcare providers seek more cost-effective or environmentally friendly options.
The global Sevoflurane market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Hengrui
Baxter
Maruishi
AbbVie
Piramal
Viatris
PT Novell Pharmaceutical
Lunan Pharma
By Type: (Dominant Segment vs High-Margin Innovation)
Generic Drug
Original Drug
By Application: (Core Demand Driver vs Emerging Opportunity)
Hospital
Clinics
Other
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Hengrui in Europe)
- Emerging Product Trends: Generic Drug adoption vs. Original Drug premiumization
- Demand-Side Dynamics: Hospital growth in China vs. Clinics potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
India
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Sevoflurane market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Original Drug in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Clinics in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Generic Drug dominance in Europe vs. Original Drug demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.
The key driver for the Sevoflurane market is the increasing number of surgeries worldwide, driven by the aging population and the rising prevalence of chronic conditions requiring surgical intervention. Sevoflurane is highly preferred due to its rapid onset and recovery, making it ideal for both pediatric and adult patients, particularly in outpatient surgeries. Technological advancements in anesthesia delivery systems and the growing demand for minimally invasive procedures have also contributed to the rising adoption of Sevoflurane in clinical settings. Furthermore, the safety and effectiveness of Sevoflurane in maintaining stable cardiovascular function during anesthesia have enhanced its demand.
One of the main challenges in the Sevoflurane market is its high cost compared to other anesthetic agents, which can limit its accessibility in low- and middle-income regions. Additionally, environmental concerns regarding the use of volatile anesthetics like Sevoflurane, which contribute to greenhouse gas emissions, have led to increased scrutiny and calls for more sustainable alternatives. Regulatory restrictions and the availability of generic alternatives may further impact the market growth, as healthcare providers seek more cost-effective or environmentally friendly options.
The global Sevoflurane market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Hengrui
Baxter
Maruishi
AbbVie
Piramal
Viatris
PT Novell Pharmaceutical
Lunan Pharma
By Type: (Dominant Segment vs High-Margin Innovation)
Generic Drug
Original Drug
By Application: (Core Demand Driver vs Emerging Opportunity)
Hospital
Clinics
Other
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Hengrui in Europe)
- Emerging Product Trends: Generic Drug adoption vs. Original Drug premiumization
- Demand-Side Dynamics: Hospital growth in China vs. Clinics potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
India
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Sevoflurane market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Original Drug in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Clinics in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Generic Drug dominance in Europe vs. Original Drug demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
1 Market Overview
1.1 Sevoflurane Product Scope
1.2 Sevoflurane by Type
1.2.1 Global Sevoflurane Sales by Type (2020 & 2024 & 2031)
1.2.2 Generic Drug
1.2.3 Original Drug
1.3 Sevoflurane by Application
1.3.1 Global Sevoflurane Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Global Sevoflurane Market Estimates and Forecasts (2020-2031)
1.4.1 Global Sevoflurane Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Sevoflurane Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Sevoflurane Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Sevoflurane Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Sevoflurane Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Sevoflurane Sales Market Share by Region (2020-2025)
2.2.2 Global Sevoflurane Revenue Market Share by Region (2020-2025)
2.3 Global Sevoflurane Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Sevoflurane Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Sevoflurane Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Sevoflurane Market Size and Prospective (2020-2031)
2.4.2 Europe Sevoflurane Market Size and Prospective (2020-2031)
2.4.3 China Sevoflurane Market Size and Prospective (2020-2031)
2.4.4 Japan Sevoflurane Market Size and Prospective (2020-2031)
2.4.5 India Sevoflurane Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Sevoflurane Historic Market Review by Type (2020-2025)
3.1.1 Global Sevoflurane Sales by Type (2020-2025)
3.1.2 Global Sevoflurane Revenue by Type (2020-2025)
3.1.3 Global Sevoflurane Price by Type (2020-2025)
3.2 Global Sevoflurane Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Sevoflurane Sales Forecast by Type (2026-2031)
3.2.2 Global Sevoflurane Revenue Forecast by Type (2026-2031)
3.2.3 Global Sevoflurane Price Forecast by Type (2026-2031)
3.3 Different Types Sevoflurane Representative Players
4 Global Market Size by Application
4.1 Global Sevoflurane Historic Market Review by Application (2020-2025)
4.1.1 Global Sevoflurane Sales by Application (2020-2025)
4.1.2 Global Sevoflurane Revenue by Application (2020-2025)
4.1.3 Global Sevoflurane Price by Application (2020-2025)
4.2 Global Sevoflurane Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Sevoflurane Sales Forecast by Application (2026-2031)
4.2.2 Global Sevoflurane Revenue Forecast by Application (2026-2031)
4.2.3 Global Sevoflurane Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Sevoflurane Application
5 Competition Landscape by Players
5.1 Global Sevoflurane Sales by Players (2020-2025)
5.2 Global Top Sevoflurane Players by Revenue (2020-2025)
5.3 Global Sevoflurane Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sevoflurane as of 2024)
5.4 Global Sevoflurane Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Sevoflurane, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Sevoflurane, Product Type & Application
5.7 Global Key Manufacturers of Sevoflurane, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Sevoflurane Sales by Company
6.1.1.1 North America Sevoflurane Sales by Company (2020-2025)
6.1.1.2 North America Sevoflurane Revenue by Company (2020-2025)
6.1.2 North America Sevoflurane Sales Breakdown by Type (2020-2025)
6.1.3 North America Sevoflurane Sales Breakdown by Application (2020-2025)
6.1.4 North America Sevoflurane Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Sevoflurane Sales by Company
6.2.1.1 Europe Sevoflurane Sales by Company (2020-2025)
6.2.1.2 Europe Sevoflurane Revenue by Company (2020-2025)
6.2.2 Europe Sevoflurane Sales Breakdown by Type (2020-2025)
6.2.3 Europe Sevoflurane Sales Breakdown by Application (2020-2025)
6.2.4 Europe Sevoflurane Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Sevoflurane Sales by Company
6.3.1.1 China Sevoflurane Sales by Company (2020-2025)
6.3.1.2 China Sevoflurane Revenue by Company (2020-2025)
6.3.2 China Sevoflurane Sales Breakdown by Type (2020-2025)
6.3.3 China Sevoflurane Sales Breakdown by Application (2020-2025)
6.3.4 China Sevoflurane Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Sevoflurane Sales by Company
6.4.1.1 Japan Sevoflurane Sales by Company (2020-2025)
6.4.1.2 Japan Sevoflurane Revenue by Company (2020-2025)
6.4.2 Japan Sevoflurane Sales Breakdown by Type (2020-2025)
6.4.3 Japan Sevoflurane Sales Breakdown by Application (2020-2025)
6.4.4 Japan Sevoflurane Major Customer
6.4.5 Japan Market Trend and Opportunities
6.5 India Market: Players, Segments, Downstream and Major Customers
6.5.1 India Sevoflurane Sales by Company
6.5.1.1 India Sevoflurane Sales by Company (2020-2025)
6.5.1.2 India Sevoflurane Revenue by Company (2020-2025)
6.5.2 India Sevoflurane Sales Breakdown by Type (2020-2025)
6.5.3 India Sevoflurane Sales Breakdown by Application (2020-2025)
6.5.4 India Sevoflurane Major Customer
6.5.5 India Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Hengrui
7.1.1 Hengrui Company Information
7.1.2 Hengrui Business Overview
7.1.3 Hengrui Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Hengrui Sevoflurane Products Offered
7.1.5 Hengrui Recent Development
7.2 Baxter
7.2.1 Baxter Company Information
7.2.2 Baxter Business Overview
7.2.3 Baxter Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Baxter Sevoflurane Products Offered
7.2.5 Baxter Recent Development
7.3 Maruishi
7.3.1 Maruishi Company Information
7.3.2 Maruishi Business Overview
7.3.3 Maruishi Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Maruishi Sevoflurane Products Offered
7.3.5 Maruishi Recent Development
7.4 AbbVie
7.4.1 AbbVie Company Information
7.4.2 AbbVie Business Overview
7.4.3 AbbVie Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
7.4.4 AbbVie Sevoflurane Products Offered
7.4.5 AbbVie Recent Development
7.5 Piramal
7.5.1 Piramal Company Information
7.5.2 Piramal Business Overview
7.5.3 Piramal Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Piramal Sevoflurane Products Offered
7.5.5 Piramal Recent Development
7.6 Viatris
7.6.1 Viatris Company Information
7.6.2 Viatris Business Overview
7.6.3 Viatris Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Viatris Sevoflurane Products Offered
7.6.5 Viatris Recent Development
7.7 PT Novell Pharmaceutical
7.7.1 PT Novell Pharmaceutical Company Information
7.7.2 PT Novell Pharmaceutical Business Overview
7.7.3 PT Novell Pharmaceutical Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
7.7.4 PT Novell Pharmaceutical Sevoflurane Products Offered
7.7.5 PT Novell Pharmaceutical Recent Development
7.8 Lunan Pharma
7.8.1 Lunan Pharma Company Information
7.8.2 Lunan Pharma Business Overview
7.8.3 Lunan Pharma Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Lunan Pharma Sevoflurane Products Offered
7.8.5 Lunan Pharma Recent Development
8 Sevoflurane Manufacturing Cost Analysis
8.1 Sevoflurane Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Sevoflurane
8.4 Sevoflurane Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Sevoflurane Distributors List
9.3 Sevoflurane Customers
10 Sevoflurane Market Dynamics
10.1 Sevoflurane Industry Trends
10.2 Sevoflurane Market Drivers
10.3 Sevoflurane Market Challenges
10.4 Sevoflurane Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
1.1 Sevoflurane Product Scope
1.2 Sevoflurane by Type
1.2.1 Global Sevoflurane Sales by Type (2020 & 2024 & 2031)
1.2.2 Generic Drug
1.2.3 Original Drug
1.3 Sevoflurane by Application
1.3.1 Global Sevoflurane Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Global Sevoflurane Market Estimates and Forecasts (2020-2031)
1.4.1 Global Sevoflurane Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Sevoflurane Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Sevoflurane Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Sevoflurane Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Sevoflurane Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Sevoflurane Sales Market Share by Region (2020-2025)
2.2.2 Global Sevoflurane Revenue Market Share by Region (2020-2025)
2.3 Global Sevoflurane Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Sevoflurane Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Sevoflurane Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Sevoflurane Market Size and Prospective (2020-2031)
2.4.2 Europe Sevoflurane Market Size and Prospective (2020-2031)
2.4.3 China Sevoflurane Market Size and Prospective (2020-2031)
2.4.4 Japan Sevoflurane Market Size and Prospective (2020-2031)
2.4.5 India Sevoflurane Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Sevoflurane Historic Market Review by Type (2020-2025)
3.1.1 Global Sevoflurane Sales by Type (2020-2025)
3.1.2 Global Sevoflurane Revenue by Type (2020-2025)
3.1.3 Global Sevoflurane Price by Type (2020-2025)
3.2 Global Sevoflurane Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Sevoflurane Sales Forecast by Type (2026-2031)
3.2.2 Global Sevoflurane Revenue Forecast by Type (2026-2031)
3.2.3 Global Sevoflurane Price Forecast by Type (2026-2031)
3.3 Different Types Sevoflurane Representative Players
4 Global Market Size by Application
4.1 Global Sevoflurane Historic Market Review by Application (2020-2025)
4.1.1 Global Sevoflurane Sales by Application (2020-2025)
4.1.2 Global Sevoflurane Revenue by Application (2020-2025)
4.1.3 Global Sevoflurane Price by Application (2020-2025)
4.2 Global Sevoflurane Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Sevoflurane Sales Forecast by Application (2026-2031)
4.2.2 Global Sevoflurane Revenue Forecast by Application (2026-2031)
4.2.3 Global Sevoflurane Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Sevoflurane Application
5 Competition Landscape by Players
5.1 Global Sevoflurane Sales by Players (2020-2025)
5.2 Global Top Sevoflurane Players by Revenue (2020-2025)
5.3 Global Sevoflurane Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sevoflurane as of 2024)
5.4 Global Sevoflurane Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Sevoflurane, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Sevoflurane, Product Type & Application
5.7 Global Key Manufacturers of Sevoflurane, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Sevoflurane Sales by Company
6.1.1.1 North America Sevoflurane Sales by Company (2020-2025)
6.1.1.2 North America Sevoflurane Revenue by Company (2020-2025)
6.1.2 North America Sevoflurane Sales Breakdown by Type (2020-2025)
6.1.3 North America Sevoflurane Sales Breakdown by Application (2020-2025)
6.1.4 North America Sevoflurane Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Sevoflurane Sales by Company
6.2.1.1 Europe Sevoflurane Sales by Company (2020-2025)
6.2.1.2 Europe Sevoflurane Revenue by Company (2020-2025)
6.2.2 Europe Sevoflurane Sales Breakdown by Type (2020-2025)
6.2.3 Europe Sevoflurane Sales Breakdown by Application (2020-2025)
6.2.4 Europe Sevoflurane Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Sevoflurane Sales by Company
6.3.1.1 China Sevoflurane Sales by Company (2020-2025)
6.3.1.2 China Sevoflurane Revenue by Company (2020-2025)
6.3.2 China Sevoflurane Sales Breakdown by Type (2020-2025)
6.3.3 China Sevoflurane Sales Breakdown by Application (2020-2025)
6.3.4 China Sevoflurane Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Sevoflurane Sales by Company
6.4.1.1 Japan Sevoflurane Sales by Company (2020-2025)
6.4.1.2 Japan Sevoflurane Revenue by Company (2020-2025)
6.4.2 Japan Sevoflurane Sales Breakdown by Type (2020-2025)
6.4.3 Japan Sevoflurane Sales Breakdown by Application (2020-2025)
6.4.4 Japan Sevoflurane Major Customer
6.4.5 Japan Market Trend and Opportunities
6.5 India Market: Players, Segments, Downstream and Major Customers
6.5.1 India Sevoflurane Sales by Company
6.5.1.1 India Sevoflurane Sales by Company (2020-2025)
6.5.1.2 India Sevoflurane Revenue by Company (2020-2025)
6.5.2 India Sevoflurane Sales Breakdown by Type (2020-2025)
6.5.3 India Sevoflurane Sales Breakdown by Application (2020-2025)
6.5.4 India Sevoflurane Major Customer
6.5.5 India Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Hengrui
7.1.1 Hengrui Company Information
7.1.2 Hengrui Business Overview
7.1.3 Hengrui Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Hengrui Sevoflurane Products Offered
7.1.5 Hengrui Recent Development
7.2 Baxter
7.2.1 Baxter Company Information
7.2.2 Baxter Business Overview
7.2.3 Baxter Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Baxter Sevoflurane Products Offered
7.2.5 Baxter Recent Development
7.3 Maruishi
7.3.1 Maruishi Company Information
7.3.2 Maruishi Business Overview
7.3.3 Maruishi Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Maruishi Sevoflurane Products Offered
7.3.5 Maruishi Recent Development
7.4 AbbVie
7.4.1 AbbVie Company Information
7.4.2 AbbVie Business Overview
7.4.3 AbbVie Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
7.4.4 AbbVie Sevoflurane Products Offered
7.4.5 AbbVie Recent Development
7.5 Piramal
7.5.1 Piramal Company Information
7.5.2 Piramal Business Overview
7.5.3 Piramal Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Piramal Sevoflurane Products Offered
7.5.5 Piramal Recent Development
7.6 Viatris
7.6.1 Viatris Company Information
7.6.2 Viatris Business Overview
7.6.3 Viatris Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Viatris Sevoflurane Products Offered
7.6.5 Viatris Recent Development
7.7 PT Novell Pharmaceutical
7.7.1 PT Novell Pharmaceutical Company Information
7.7.2 PT Novell Pharmaceutical Business Overview
7.7.3 PT Novell Pharmaceutical Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
7.7.4 PT Novell Pharmaceutical Sevoflurane Products Offered
7.7.5 PT Novell Pharmaceutical Recent Development
7.8 Lunan Pharma
7.8.1 Lunan Pharma Company Information
7.8.2 Lunan Pharma Business Overview
7.8.3 Lunan Pharma Sevoflurane Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Lunan Pharma Sevoflurane Products Offered
7.8.5 Lunan Pharma Recent Development
8 Sevoflurane Manufacturing Cost Analysis
8.1 Sevoflurane Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Sevoflurane
8.4 Sevoflurane Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Sevoflurane Distributors List
9.3 Sevoflurane Customers
10 Sevoflurane Market Dynamics
10.1 Sevoflurane Industry Trends
10.2 Sevoflurane Market Drivers
10.3 Sevoflurane Market Challenges
10.4 Sevoflurane Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Sevoflurane Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Sevoflurane Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Sevoflurane Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Sevoflurane Sales (K Units) by Region (2020-2025)
Table 5. Global Sevoflurane Sales Market Share by Region (2020-2025)
Table 6. Global Sevoflurane Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Sevoflurane Revenue Share by Region (2020-2025)
Table 8. Global Sevoflurane Sales (K Units) Forecast by Region (2026-2031)
Table 9. Global Sevoflurane Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Sevoflurane Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Sevoflurane Revenue Share Forecast by Region (2026-2031)
Table 12. Global Sevoflurane Sales by Type (K Units) & (2020-2025)
Table 13. Global Sevoflurane Sales Share by Type (2020-2025)
Table 14. Global Sevoflurane Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Sevoflurane Price by Type (US$/Unit) & (2020-2025)
Table 16. Global Sevoflurane Sales by Type (K Units) & (2026-2031)
Table 17. Global Sevoflurane Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Sevoflurane Price by Type (US$/Unit) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Sevoflurane Sales by Application (K Units) & (2020-2025)
Table 21. Global Sevoflurane Sales Share by Application (2020-2025)
Table 22. Global Sevoflurane Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Sevoflurane Price by Application (US$/Unit) & (2020-2025)
Table 24. Global Sevoflurane Sales by Application (K Units) & (2026-2031)
Table 25. Global Sevoflurane Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Sevoflurane Price by Application (US$/Unit) & (2026-2031)
Table 27. New Sources of Growth in Sevoflurane Application
Table 28. Global Sevoflurane Sales by Company (K Units) & (2020-2025)
Table 29. Global Sevoflurane Sales Share by Company (2020-2025)
Table 30. Global Sevoflurane Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Sevoflurane Revenue Share by Company (2020-2025)
Table 32. Global Sevoflurane by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sevoflurane as of 2024)
Table 33. Global Market Sevoflurane Average Price by Company (US$/Unit) & (2020-2025)
Table 34. Global Key Manufacturers of Sevoflurane, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Sevoflurane, Product Type & Application
Table 36. Global Key Manufacturers of Sevoflurane, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Sevoflurane Sales by Company (2020-2025) & (K Units)
Table 39. North America Sevoflurane Sales Market Share by Company (2020-2025)
Table 40. North America Sevoflurane Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Sevoflurane Revenue Market Share by Company (2020-2025)
Table 42. North America Sevoflurane Sales by Type (2020-2025) & (K Units)
Table 43. North America Sevoflurane Sales Market Share by Type (2020-2025)
Table 44. North America Sevoflurane Sales by Application (2020-2025) & (K Units)
Table 45. North America Sevoflurane Sales Market Share by Application (2020-2025)
Table 46. Europe Sevoflurane Sales by Company (2020-2025) & (K Units)
Table 47. Europe Sevoflurane Sales Market Share by Company (2020-2025)
Table 48. Europe Sevoflurane Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Sevoflurane Revenue Market Share by Company (2020-2025)
Table 50. Europe Sevoflurane Sales by Type (2020-2025) & (K Units)
Table 51. Europe Sevoflurane Sales Market Share by Type (2020-2025)
Table 52. Europe Sevoflurane Sales by Application (2020-2025) & (K Units)
Table 53. Europe Sevoflurane Sales Market Share by Application (2020-2025)
Table 54. China Sevoflurane Sales by Company (2020-2025) & (K Units)
Table 55. China Sevoflurane Sales Market Share by Company (2020-2025)
Table 56. China Sevoflurane Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Sevoflurane Revenue Market Share by Company (2020-2025)
Table 58. China Sevoflurane Sales by Type (2020-2025) & (K Units)
Table 59. China Sevoflurane Sales Market Share by Type (2020-2025)
Table 60. China Sevoflurane Sales by Application (2020-2025) & (K Units)
Table 61. China Sevoflurane Sales Market Share by Application (2020-2025)
Table 62. Japan Sevoflurane Sales by Company (2020-2025) & (K Units)
Table 63. Japan Sevoflurane Sales Market Share by Company (2020-2025)
Table 64. Japan Sevoflurane Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Sevoflurane Revenue Market Share by Company (2020-2025)
Table 66. Japan Sevoflurane Sales by Type (2020-2025) & (K Units)
Table 67. Japan Sevoflurane Sales Market Share by Type (2020-2025)
Table 68. Japan Sevoflurane Sales by Application (2020-2025) & (K Units)
Table 69. Japan Sevoflurane Sales Market Share by Application (2020-2025)
Table 70. India Sevoflurane Sales by Company (2020-2025) & (K Units)
Table 71. India Sevoflurane Sales Market Share by Company (2020-2025)
Table 72. India Sevoflurane Revenue by Company (2020-2025) & (US$ Million)
Table 73. India Sevoflurane Revenue Market Share by Company (2020-2025)
Table 74. India Sevoflurane Sales by Type (2020-2025) & (K Units)
Table 75. India Sevoflurane Sales Market Share by Type (2020-2025)
Table 76. India Sevoflurane Sales by Application (2020-2025) & (K Units)
Table 77. India Sevoflurane Sales Market Share by Application (2020-2025)
Table 78. Hengrui Company Information
Table 79. Hengrui Description and Business Overview
Table 80. Hengrui Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Hengrui Sevoflurane Product
Table 82. Hengrui Recent Development
Table 83. Baxter Company Information
Table 84. Baxter Description and Business Overview
Table 85. Baxter Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 86. Baxter Sevoflurane Product
Table 87. Baxter Recent Development
Table 88. Maruishi Company Information
Table 89. Maruishi Description and Business Overview
Table 90. Maruishi Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 91. Maruishi Sevoflurane Product
Table 92. Maruishi Recent Development
Table 93. AbbVie Company Information
Table 94. AbbVie Description and Business Overview
Table 95. AbbVie Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. AbbVie Sevoflurane Product
Table 97. AbbVie Recent Development
Table 98. Piramal Company Information
Table 99. Piramal Description and Business Overview
Table 100. Piramal Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 101. Piramal Sevoflurane Product
Table 102. Piramal Recent Development
Table 103. Viatris Company Information
Table 104. Viatris Description and Business Overview
Table 105. Viatris Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 106. Viatris Sevoflurane Product
Table 107. Viatris Recent Development
Table 108. PT Novell Pharmaceutical Company Information
Table 109. PT Novell Pharmaceutical Description and Business Overview
Table 110. PT Novell Pharmaceutical Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 111. PT Novell Pharmaceutical Sevoflurane Product
Table 112. PT Novell Pharmaceutical Recent Development
Table 113. Lunan Pharma Company Information
Table 114. Lunan Pharma Description and Business Overview
Table 115. Lunan Pharma Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 116. Lunan Pharma Sevoflurane Product
Table 117. Lunan Pharma Recent Development
Table 118. Production Base and Market Concentration Rate of Raw Material
Table 119. Key Suppliers of Raw Materials
Table 120. Sevoflurane Distributors List
Table 121. Sevoflurane Customers List
Table 122. Sevoflurane Market Trends
Table 123. Sevoflurane Market Drivers
Table 124. Sevoflurane Market Challenges
Table 125. Sevoflurane Market Restraints
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Sevoflurane Product Picture
Figure 2. Global Sevoflurane Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Sevoflurane Sales Market Share by Type in 2024 & 2031
Figure 4. Generic Drug Product Picture
Figure 5. Original Drug Product Picture
Figure 6. Global Sevoflurane Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Sevoflurane Sales Market Share by Application in 2024 & 2031
Figure 8. Hospital Examples
Figure 9. Clinics Examples
Figure 10. Other Examples
Figure 11. Global Sevoflurane Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Sevoflurane Sales Growth Rate (2020-2031) & (US$ Million)
Figure 13. Global Sevoflurane Sales (K Units) Growth Rate (2020-2031)
Figure 14. Global Sevoflurane Price Trends Growth Rate (2020-2031) & (US$/Unit)
Figure 15. Sevoflurane Report Years Considered
Figure 16. Global Market Sevoflurane Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 17. Global Sevoflurane Revenue Market Share by Region: 2020 VS 2024
Figure 18. North America Sevoflurane Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. North America Sevoflurane Sales (K Units) Growth Rate (2020-2031)
Figure 20. Europe Sevoflurane Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Europe Sevoflurane Sales (K Units) Growth Rate (2020-2031)
Figure 22. China Sevoflurane Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. China Sevoflurane Sales (K Units) Growth Rate (2020-2031)
Figure 24. Japan Sevoflurane Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. Japan Sevoflurane Sales (K Units) Growth Rate (2020-2031)
Figure 26. India Sevoflurane Revenue (US$ Million) Growth Rate (2020-2031)
Figure 27. India Sevoflurane Sales (K Units) Growth Rate (2020-2031)
Figure 28. Global Sevoflurane Revenue Share by Type (2020-2025)
Figure 29. Global Sevoflurane Sales Share by Type (2026-2031)
Figure 30. Global Sevoflurane Revenue Share by Type (2026-2031)
Figure 31. Global Sevoflurane Revenue Share by Application (2020-2025)
Figure 32. Global Sevoflurane Revenue Growth Rate by Application in 2020 & 2024
Figure 33. Global Sevoflurane Sales Share by Application (2026-2031)
Figure 34. Global Sevoflurane Revenue Share by Application (2026-2031)
Figure 35. Global Sevoflurane Sales Share by Company (2024)
Figure 36. Global Sevoflurane Revenue Share by Company (2024)
Figure 37. Global 5 Largest Sevoflurane Players Market Share by Revenue in Sevoflurane: 2020 & 2024
Figure 38. Sevoflurane Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 39. Manufacturing Cost Structure of Sevoflurane
Figure 40. Manufacturing Process Analysis of Sevoflurane
Figure 41. Sevoflurane Industrial Chain
Figure 42. Channels of Distribution (Direct Vs Distribution)
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
Table 1. Global Sevoflurane Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Sevoflurane Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Sevoflurane Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Sevoflurane Sales (K Units) by Region (2020-2025)
Table 5. Global Sevoflurane Sales Market Share by Region (2020-2025)
Table 6. Global Sevoflurane Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Sevoflurane Revenue Share by Region (2020-2025)
Table 8. Global Sevoflurane Sales (K Units) Forecast by Region (2026-2031)
Table 9. Global Sevoflurane Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Sevoflurane Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Sevoflurane Revenue Share Forecast by Region (2026-2031)
Table 12. Global Sevoflurane Sales by Type (K Units) & (2020-2025)
Table 13. Global Sevoflurane Sales Share by Type (2020-2025)
Table 14. Global Sevoflurane Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Sevoflurane Price by Type (US$/Unit) & (2020-2025)
Table 16. Global Sevoflurane Sales by Type (K Units) & (2026-2031)
Table 17. Global Sevoflurane Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Sevoflurane Price by Type (US$/Unit) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Sevoflurane Sales by Application (K Units) & (2020-2025)
Table 21. Global Sevoflurane Sales Share by Application (2020-2025)
Table 22. Global Sevoflurane Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Sevoflurane Price by Application (US$/Unit) & (2020-2025)
Table 24. Global Sevoflurane Sales by Application (K Units) & (2026-2031)
Table 25. Global Sevoflurane Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Sevoflurane Price by Application (US$/Unit) & (2026-2031)
Table 27. New Sources of Growth in Sevoflurane Application
Table 28. Global Sevoflurane Sales by Company (K Units) & (2020-2025)
Table 29. Global Sevoflurane Sales Share by Company (2020-2025)
Table 30. Global Sevoflurane Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Sevoflurane Revenue Share by Company (2020-2025)
Table 32. Global Sevoflurane by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sevoflurane as of 2024)
Table 33. Global Market Sevoflurane Average Price by Company (US$/Unit) & (2020-2025)
Table 34. Global Key Manufacturers of Sevoflurane, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Sevoflurane, Product Type & Application
Table 36. Global Key Manufacturers of Sevoflurane, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Sevoflurane Sales by Company (2020-2025) & (K Units)
Table 39. North America Sevoflurane Sales Market Share by Company (2020-2025)
Table 40. North America Sevoflurane Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Sevoflurane Revenue Market Share by Company (2020-2025)
Table 42. North America Sevoflurane Sales by Type (2020-2025) & (K Units)
Table 43. North America Sevoflurane Sales Market Share by Type (2020-2025)
Table 44. North America Sevoflurane Sales by Application (2020-2025) & (K Units)
Table 45. North America Sevoflurane Sales Market Share by Application (2020-2025)
Table 46. Europe Sevoflurane Sales by Company (2020-2025) & (K Units)
Table 47. Europe Sevoflurane Sales Market Share by Company (2020-2025)
Table 48. Europe Sevoflurane Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Sevoflurane Revenue Market Share by Company (2020-2025)
Table 50. Europe Sevoflurane Sales by Type (2020-2025) & (K Units)
Table 51. Europe Sevoflurane Sales Market Share by Type (2020-2025)
Table 52. Europe Sevoflurane Sales by Application (2020-2025) & (K Units)
Table 53. Europe Sevoflurane Sales Market Share by Application (2020-2025)
Table 54. China Sevoflurane Sales by Company (2020-2025) & (K Units)
Table 55. China Sevoflurane Sales Market Share by Company (2020-2025)
Table 56. China Sevoflurane Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Sevoflurane Revenue Market Share by Company (2020-2025)
Table 58. China Sevoflurane Sales by Type (2020-2025) & (K Units)
Table 59. China Sevoflurane Sales Market Share by Type (2020-2025)
Table 60. China Sevoflurane Sales by Application (2020-2025) & (K Units)
Table 61. China Sevoflurane Sales Market Share by Application (2020-2025)
Table 62. Japan Sevoflurane Sales by Company (2020-2025) & (K Units)
Table 63. Japan Sevoflurane Sales Market Share by Company (2020-2025)
Table 64. Japan Sevoflurane Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Sevoflurane Revenue Market Share by Company (2020-2025)
Table 66. Japan Sevoflurane Sales by Type (2020-2025) & (K Units)
Table 67. Japan Sevoflurane Sales Market Share by Type (2020-2025)
Table 68. Japan Sevoflurane Sales by Application (2020-2025) & (K Units)
Table 69. Japan Sevoflurane Sales Market Share by Application (2020-2025)
Table 70. India Sevoflurane Sales by Company (2020-2025) & (K Units)
Table 71. India Sevoflurane Sales Market Share by Company (2020-2025)
Table 72. India Sevoflurane Revenue by Company (2020-2025) & (US$ Million)
Table 73. India Sevoflurane Revenue Market Share by Company (2020-2025)
Table 74. India Sevoflurane Sales by Type (2020-2025) & (K Units)
Table 75. India Sevoflurane Sales Market Share by Type (2020-2025)
Table 76. India Sevoflurane Sales by Application (2020-2025) & (K Units)
Table 77. India Sevoflurane Sales Market Share by Application (2020-2025)
Table 78. Hengrui Company Information
Table 79. Hengrui Description and Business Overview
Table 80. Hengrui Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Hengrui Sevoflurane Product
Table 82. Hengrui Recent Development
Table 83. Baxter Company Information
Table 84. Baxter Description and Business Overview
Table 85. Baxter Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 86. Baxter Sevoflurane Product
Table 87. Baxter Recent Development
Table 88. Maruishi Company Information
Table 89. Maruishi Description and Business Overview
Table 90. Maruishi Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 91. Maruishi Sevoflurane Product
Table 92. Maruishi Recent Development
Table 93. AbbVie Company Information
Table 94. AbbVie Description and Business Overview
Table 95. AbbVie Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. AbbVie Sevoflurane Product
Table 97. AbbVie Recent Development
Table 98. Piramal Company Information
Table 99. Piramal Description and Business Overview
Table 100. Piramal Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 101. Piramal Sevoflurane Product
Table 102. Piramal Recent Development
Table 103. Viatris Company Information
Table 104. Viatris Description and Business Overview
Table 105. Viatris Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 106. Viatris Sevoflurane Product
Table 107. Viatris Recent Development
Table 108. PT Novell Pharmaceutical Company Information
Table 109. PT Novell Pharmaceutical Description and Business Overview
Table 110. PT Novell Pharmaceutical Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 111. PT Novell Pharmaceutical Sevoflurane Product
Table 112. PT Novell Pharmaceutical Recent Development
Table 113. Lunan Pharma Company Information
Table 114. Lunan Pharma Description and Business Overview
Table 115. Lunan Pharma Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 116. Lunan Pharma Sevoflurane Product
Table 117. Lunan Pharma Recent Development
Table 118. Production Base and Market Concentration Rate of Raw Material
Table 119. Key Suppliers of Raw Materials
Table 120. Sevoflurane Distributors List
Table 121. Sevoflurane Customers List
Table 122. Sevoflurane Market Trends
Table 123. Sevoflurane Market Drivers
Table 124. Sevoflurane Market Challenges
Table 125. Sevoflurane Market Restraints
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Sevoflurane Product Picture
Figure 2. Global Sevoflurane Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Sevoflurane Sales Market Share by Type in 2024 & 2031
Figure 4. Generic Drug Product Picture
Figure 5. Original Drug Product Picture
Figure 6. Global Sevoflurane Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Sevoflurane Sales Market Share by Application in 2024 & 2031
Figure 8. Hospital Examples
Figure 9. Clinics Examples
Figure 10. Other Examples
Figure 11. Global Sevoflurane Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Sevoflurane Sales Growth Rate (2020-2031) & (US$ Million)
Figure 13. Global Sevoflurane Sales (K Units) Growth Rate (2020-2031)
Figure 14. Global Sevoflurane Price Trends Growth Rate (2020-2031) & (US$/Unit)
Figure 15. Sevoflurane Report Years Considered
Figure 16. Global Market Sevoflurane Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 17. Global Sevoflurane Revenue Market Share by Region: 2020 VS 2024
Figure 18. North America Sevoflurane Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. North America Sevoflurane Sales (K Units) Growth Rate (2020-2031)
Figure 20. Europe Sevoflurane Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Europe Sevoflurane Sales (K Units) Growth Rate (2020-2031)
Figure 22. China Sevoflurane Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. China Sevoflurane Sales (K Units) Growth Rate (2020-2031)
Figure 24. Japan Sevoflurane Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. Japan Sevoflurane Sales (K Units) Growth Rate (2020-2031)
Figure 26. India Sevoflurane Revenue (US$ Million) Growth Rate (2020-2031)
Figure 27. India Sevoflurane Sales (K Units) Growth Rate (2020-2031)
Figure 28. Global Sevoflurane Revenue Share by Type (2020-2025)
Figure 29. Global Sevoflurane Sales Share by Type (2026-2031)
Figure 30. Global Sevoflurane Revenue Share by Type (2026-2031)
Figure 31. Global Sevoflurane Revenue Share by Application (2020-2025)
Figure 32. Global Sevoflurane Revenue Growth Rate by Application in 2020 & 2024
Figure 33. Global Sevoflurane Sales Share by Application (2026-2031)
Figure 34. Global Sevoflurane Revenue Share by Application (2026-2031)
Figure 35. Global Sevoflurane Sales Share by Company (2024)
Figure 36. Global Sevoflurane Revenue Share by Company (2024)
Figure 37. Global 5 Largest Sevoflurane Players Market Share by Revenue in Sevoflurane: 2020 & 2024
Figure 38. Sevoflurane Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 39. Manufacturing Cost Structure of Sevoflurane
Figure 40. Manufacturing Process Analysis of Sevoflurane
Figure 41. Sevoflurane Industrial Chain
Figure 42. Channels of Distribution (Direct Vs Distribution)
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Coke Oven Inspection Intelligent Robot Market Research Report 2025
Apr 16, 25
Global Explosion-Proof Fire Extinguishing Reconnaissance Robot Market Research Report 2025
Apr 16, 25
Global Electric Wheeled Inspection Robot Market Research Report 2025
Apr 16, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232